Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019Research in context

Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019Research in context

Summary: Background: Population-based survival studies of adult acute myeloid leukemia (AML) have not simultaneously evaluated age at diagnosis, race and ethnicity, sex, calendar period or AML subtypes/subgroups among chemotherapy-treated patients. Methods: For 28,473 chemotherapy-treated AML patie...

Full description

Bibliographic Details
Main Authors: Martha S. Linet, Rochelle E. Curtis, Sara J. Schonfeld, Jacqueline B. Vo, Lindsay M. Morton, Graça M. Dores
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:EClinicalMedicine
Subjects:
Acute leukemia
Myeloid leukemia
Population-based survival
Adults
Chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537024001287

Internet

http://www.sciencedirect.com/science/article/pii/S2589537024001287

Similar Items